Obsidio

company

About

Obsidio is a medical device company pioneering a biomaterial platform technology to enable minimally-invasive occlusion of blood vessels.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$225K
Industries
Health Care,Medical Device
Founded date
Dec 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

Obsidio, Inc. is an early-stage medical device company pioneering a biomaterial platform technology to enable minimally-invasive occlusion of blood vessels anywhere in the body regardless of the patient’s coagulopathy. The technology can be used to control bleeding, close off vessels supplying blood to tumor, eliminate abnormal connections between arteries and veins, and treat aneurysms.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$225K
Obsidio has raised a total of $225K in funding over 2 rounds. Their latest funding was raised on Aug 6, 2020 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 6, 2020 Grant $225K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Obsidio is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant